Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women

Article Abstract:

Over 2 to 8 years, participants in the estrogen plus progestin trial of the Women's Health Initiative at the University of California Davis had annual pelvic examinations, with an assessment of uterine prolapse, cystocele, and rectocele. The results suggest that pelvic organ prolapse is not always chronic and progressive as traditionally thought.

Evaluation, Uterus, Uterine prolapse

---

Parity and route of delivery: Does cesarean delivery reduce bladder symptoms later in life?

Article Abstract:

The impact of reproductive factors on the prevalence of urinary symptoms is investigated. It was found that women who have undergone vaginal delivery are more likely to report stress incontinence than women who have delivered by cesarean section, indicating that cesarean delivery might reduce incontinence later in life.

United States, Science & research, Research, Causes of, Cesarean section, Urination disorders, Bladder diseases

---

Pelvic organ descent in young nulligravid women

Article Abstract:

The data on urethral, bladder, cervical and rectal descent in a cohort of young, white nulligravid nonpregnant women are presented. The average for bladder neck descent on Valsalva was observed as17 mm.

Analysis, Valsalva's maneuver

Similar abstracts:

• Abstracts: Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction
• Abstracts: Perspective on mitral-valve prolapse. Preventing coronary restenosis and complications. Hypertrophic obstructive cardiomyopathy
• Abstracts: Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction
• Abstracts: Provocation of Coronary vasospastic angina using an Isoproterenol head-up Tilt Test. Prevention of Recurrent Deep Venous Thrombosis with Sulodexide: the Sanval registry
• Abstracts: Problems with drug-eluting coronary stents-the FDA perspective. Drug-induced prolongation of the QT interval

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.